TBC-3711

Known as: TBC 3711, TBC3711 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2010
01220012010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND Endothelin-1 signalling plays an important role in pathogenesis of pulmonary hypertension. Although different… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
BACKGROUND Endothelin-1 is a potent endogenous vasoconstrictor that contributes to renal microcirculatory impairment during… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
BACKGROUND The potent vasoconstrictor endothelin-1 has been implicated in the pathogenesis of the microcirculatory dysfunction… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2010
2010
OBJECTIVES In patients with chronic thromboembolic pulmonary hypertension, high flow in unobstructed lung regions may induce… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
Sitaxsentan (1) (Wu et al. J. Med. Chem. 1997, 40, 1690) is our first endothelin antagonist being evaluated in clinical trials… (More)
Is this relevant?
2001
2001
The pulmonary vasculature of newborns with persistent pulmonary hypertension is characterized by active vasoconstriction and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?